|
HY-13318-100mg
|
MedChemexpress LLC
|
Oseltamivir acid [CAS 187227-45-8]
|
|
COVID-19-anti-virus
|
|
|
HY-13318-5mg
|
MedChemexpress LLC
|
Oseltamivir acid [CAS 187227-45-8]
|
|
COVID-19-anti-virus
|
|
|
HY-13318-50mg
|
MedChemexpress LLC
|
Oseltamivir acid [CAS 187227-45-8]
|
|
COVID-19-anti-virus
|
|
|
HY-13318-1mL
|
MedChemexpress LLC
|
Oseltamivir acid [CAS 187227-45-8] (10mM in DMSO)
|
|
COVID-19-anti-virus
|
|
|
HY-13318S-1mg
|
MedChemexpress LLC
|
Oseltamivir acid-d3 [CAS 1242184-43-5]
|
|
COVID-19-anti-virus
|
|
|
HY-13318S-10mg
|
MedChemexpress LLC
|
Oseltamivir acid-d3 [CAS 1242184-43-5]
|
|
COVID-19-anti-virus
|
|
|
HY-13318S-5mg
|
MedChemexpress LLC
|
Oseltamivir acid-d3 [CAS 1242184-43-5]
|
|
COVID-19-anti-virus
|
|
|
HY-P0221-1mg
|
MedChemexpress LLC
|
PACAP (1-38), human, ovine, rat [CAS 137061-48-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P0221-5mg
|
MedChemexpress LLC
|
PACAP (1-38), human, ovine, rat [CAS 137061-48-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P0221-500ug
|
MedChemexpress LLC
|
PACAP (1-38), human, ovine, rat [CAS 137061-48-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-W010907-100mg
|
MedChemexpress LLC
|
Pamoic acid (disodium) [CAS 6640-22-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-W010907-1mL
|
MedChemexpress LLC
|
Pamoic acid (disodium) [CAS 6640-22-8] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-W008613-1g
|
MedChemexpress LLC
|
Pamoic acid [CAS 130-85-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-W110929-100mg
|
MedChemexpress LLC
|
Patent Blue V [CAS 129-17-9]
|
|
Cancer-programmed cell death
|
|
|
HY-W110929-500mg
|
MedChemexpress LLC
|
Patent Blue V [CAS 129-17-9]
|
|
Cancer-programmed cell death
|
|
|
HY-153219-1mg
|
MedChemexpress LLC
|
P-CAB agent 2 (hydrochloride) [CAS 2209911-80-6]
|
|
|
|
|
HY-153219-10mg
|
MedChemexpress LLC
|
P-CAB agent 2 (hydrochloride) [CAS 2209911-80-6]
|
|
|
|
|
HY-153219-100mg
|
MedChemexpress LLC
|
P-CAB agent 2 (hydrochloride) [CAS 2209911-80-6]
|
|
|
|
|
HY-153219-25mg
|
MedChemexpress LLC
|
P-CAB agent 2 (hydrochloride) [CAS 2209911-80-6]
|
|
|
|
|
HY-153219-5mg
|
MedChemexpress LLC
|
P-CAB agent 2 (hydrochloride) [CAS 2209911-80-6]
|
|
|
|
|
HY-153219-50mg
|
MedChemexpress LLC
|
P-CAB agent 2 (hydrochloride) [CAS 2209911-80-6]
|
|
|
|
|
HY-153219A-1mg
|
MedChemexpress LLC
|
P-CAB agent 2 [CAS 1978371-23-1]
|
|
|
|
|
HY-153219A-10mg
|
MedChemexpress LLC
|
P-CAB agent 2 [CAS 1978371-23-1]
|
|
|
|
|
HY-153219A-100mg
|
MedChemexpress LLC
|
P-CAB agent 2 [CAS 1978371-23-1]
|
|
|
|
|
HY-153219A-25mg
|
MedChemexpress LLC
|
P-CAB agent 2 [CAS 1978371-23-1]
|
|
|
|
